Managed Account Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
$578M Sell
10,633,440
-732,091
-6% -$41.1M 0.48% 41
2015
Q1
$623M Sell
11,365,531
-554,275
-5% -$31.4M 0.55% 34
2014
Q4
$646M Sell
11,919,806
-204,403
-2% -$11.4M 0.64% 20
2014
Q3
$686M Buy
12,124,209
+1,431,311
+13% +$80.4M 0.76% 11
2014
Q2
$590M Buy
10,692,898
+267,076
+3% +$14.6M 0.71% 14
2014
Q1
$565M Sell
10,425,822
-29,274
-0.3% -$1.52M 0.74% 11
2013
Q4
$499M Buy
10,455,096
+456,065
+5% +$20.8M 0.67% 17
2013
Q3
$454M Sell
9,999,031
-470,982
-4% -$21.5M 0.67% 15
2013
Q2
$464M Buy
+10,470,013
New +$468M 0.72% 15

Other funds holding MRK

Managed Account Advisors's MRK Position: Q2 2015 in Review

Managed Account Advisors reduced its Merck (MRK) stake by 6.4% in Q2 2015, selling an estimated $41.1M and leaving 10,633,440 shares worth $578M. The position accounts for 0.48% of the portfolio, ranked #41.

Managed Account Advisors first reported a position in MRK in Q2 2013 and has held it in 9 quarters since. The position peaked at $686M in Q3 2014. 1,726 funds tracked by Wall St. Rank hold MRK as of Q2 2015.

  • Managed Account Advisors held 10,633,440 shares of Merck worth $578M as of Q2 2015.
  • Managed Account Advisors sold 732,091 Merck shares in Q2 2015, an estimated $41.1M.
  • Merck made up 0.48% of Managed Account Advisors's portfolio in Q2 2015, its #41 holding.
  • Managed Account Advisors first reported a position in Merck in Q2 2013 and has held it in 9 quarters since.
  • Managed Account Advisors's Merck position peaked at $686M in Q3 2014.
  • 1,726 funds tracked by Wall St. Rank held Merck as of Q2 2015.

Based on Managed Account Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.